SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001564590-19-043898
Filing Date
2019-11-20
Accepted
2019-11-19 17:38:46
Documents
11
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A ttoo-10qa_20190930.htm 10-Q/A 2067648
2 EX-10.1 ttoo-ex101_10.htm EX-10.1 404911
3 EX-10.2 ttoo-ex102_13.htm EX-10.2 1377608
4 EX-31.1 ttoo-ex311_7.htm EX-31.1 16337
5 EX-31.2 ttoo-ex312_9.htm EX-31.2 16375
6 EX-32.1 ttoo-ex321_8.htm EX-32.1 5731
7 EX-32.2 ttoo-ex322_6.htm EX-32.2 5866
8 GRAPHIC gpsii0omn1jx000002.jpg GRAPHIC 1540
9 GRAPHIC gpsii0omn1jx000004.jpg GRAPHIC 2650
10 GRAPHIC gpsii0omn1jx000001.jpg GRAPHIC 115920
11 GRAPHIC gpsii0omn1jx000003.jpg GRAPHIC 2093
  Complete submission text file 0001564590-19-043898.txt   4064360
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36571 | Film No.: 191232466
SIC: 3841 Surgical & Medical Instruments & Apparatus